Dumont & Blake Investment Advisors’s AbbVie ABBV Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100	Closed	-$9K	–	169
2019 Q4	$9K	Hold	100	–	–	﹤0.01%	179
2019 Q3	$8K	Buy	+100	New	+$6.86K	﹤0.01%	176
2018 Q2	–	Sell	-1,400	Closed	-$133K	–	184
2018 Q1	$133K	Sell	1,400 -300	-18%	-$33K	0.06%	166
2017 Q4	$164K	Buy	+1,700	New	+$160K	0.07%	172

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dumont & Blake Investment Advisors's ABBV Position: Q1 2026 in Review

Dumont & Blake Investment Advisors reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $46.6K and leaving 13,133 shares worth $2.86M. The position accounts for 0.71% of the portfolio, ranked #35.

Dumont & Blake Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.87M in Q2 2024. 4,082 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Dumont & Blake Investment Advisors held 13,133 shares of AbbVie worth $2.86M as of Q1 2026.
Dumont & Blake Investment Advisors sold 210 AbbVie shares in Q1 2026, an estimated $46.6K.
AbbVie made up 0.71% of Dumont & Blake Investment Advisors's portfolio in Q1 2026, its #35 holding.
Dumont & Blake Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Dumont & Blake Investment Advisors's AbbVie position peaked at $4.87M in Q2 2024.
4,082 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.